SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001390478-18-000025
Filing Date
2018-10-02
Accepted
2018-10-02 17:21:00
Documents
1
Period of Report
2018-09-26
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K sls-20181002x8xkjgbnotice.htm 8-K 40051
  Complete submission text file 0001390478-18-000025.txt   41563
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 181102581
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences